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Infections associated with Mycobacterium haemo-
philum are underdiagnosed because specific culture meth-
ods required for its recovery are not applied routinely. Using
polymerase chain reaction (PCR) technology on fine nee-
dle aspirates and biopsied specimens from 89 children with
cervicofacial lymphadenitis, we assessed the importance of
M. haemophilum. Application of a Mycobacterium
genus–specific real-time PCR in combination with amplicon
sequencing and a M. haemophilum–specific PCR resulted
in the recognition of M. haemophilum as the causative
agent in 16 (18%) children with cervicofacial lymphadenitis.
M. avium was the most frequently found species (56%),
and M. haemophilum was the second most commonly rec-
ognized pathogen. Real-time PCR results were superior to
culture because only 9 (56%) of the 16 diagnosed
M. haemophilum infections were positive by  culture. 
C
ervicofacial lymphadenitis is the most frequently
encountered manifestation of nontuberculous
mycobacterial (NTM) disease in children. In previous
studies, Mycobacterium avium has been identified as the
cause in >80% of the patients (1). Other mycobacterial
species isolated from patients with lymphadenitis are M.
tuberculosis,  M. malmoense, M. kansasii,  M. scrofu-
laceum, M. intracellulare, and M. xenopi. M. haemophilum
has been described as the causative agent of lymphadenitis
as well (2–7). 
In an ongoing multicenter study in the Netherlands, the
optimal treatment for NTM lymphadenitis is investigated.
Diagnosis of mycobacterial infection is performed by using
mycobacterial differential skin tests and fine needle aspira-
tion biopsy. Biopsied specimens are subjected to acid-fast
staining, mycobacterial culturing, and Mycobacterium
genus–specific real-time PCR. Of 89 patients included in
the study so far, mycobacterial species were identified in 55
cases, of which M. avium had been found in 50 patients (8).
In addition, a mycobacterial infection without further iden-
tification was detected in 16 patients. An atypical mycobac-
terial infection was diagnosed in these patients because
either acid-fast staining results were positive or the
Mycobacterium genus–specific real-time polymerase chain
reaction (PCR) was positive. Cultures or species-specific
real-time PCR for M. avium and M. tuberculosis remained
negative. Previously, an attempt to characterize these
mycobacteria by sequence analysis of the genus-specific
PCR fragment was successful in only 2 cases and showed
M. haemophilum (8). In the current study, we further ana-
lyzed these uncharacterized mycobacteria.
M. haemophilum requires special growth conditions
(9), and most of the diagnostic laboratories do not use
these culture conditions. Furthermore, no molecular test is
available to detect M. haemophilum directly in clinical
materials. Therefore, M. haemophilum infection could be
seriously underdiagnosed (4,10–12). In this study, we
developed a species-specific real-time PCR to detect M.
haemophilum directly in patient materials. This assay can
show the actual prevalence of M. haemophilum in patients
with mycobacterial lymphadenitis, but it could also be
applied in other diseases and help elucidate the incidence
and distribution of this species. 
Materials and Methods 
Bacterial Strains 
Five M. haemophilum reference strains (all clinical iso-
lates) were available for 16S and internal transcribed spac-
er (ITS) sequencing. Three strains were provided by the
National Institute for Public Health and the Environment
and 2 were provided by the Institute for Tropical Medicine
(Antwerp, Belgium). The 25 mycobacterial strains used for
specificity testing included M. tuberculosis complex,
M. kansasii, M. xenopi, M. avium,  M. intracellulare,
M. gordonae, M. chelonae, M. fortuitum, M. marinum,
M. scrofulaceum, and M. malmoense.Acomplete list of all
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Bruijnesteijn et al. (8). The strains were cultured in liquid
Dubos medium at 35°C. The M. haemophilum strains were
cultured at 30°C on solid Löwenstein-Jensen (LJ) medium
with added iron citrate or in liquid Mycobacteria Growth
Index Tube (MGIT) medium with X-factor-strip added
(Becton-Dickinson, Alphen a/d Rijn, the Netherlands). 
Patients and Samples 
Clinical materials were obtained from patients included
in the CHIMED-study. In CHIMED (a multicenter nation-
wide study on the optimal treatment for children with lym-
phadenitis), treatment is randomized between surgical and
medical treatment. Pediatric patients were included on the
basis of clinical appearance of atypical mycobacterial lym-
phadenitis and a positive skin test (13,14). Fine needle
aspirates were taken from affected lymph nodes. In
patients who underwent surgical treatment, the removed
lymph nodes were also submitted for investigation. A con-
trol group to assess the specificity of the assay was assem-
bled from 50 patients with lymphadenitis caused by
Bartonella henselae. 
Mycobacterial Diagnostics 
Clinical materials were decontaminated with a Nalc-
NaOH decontamination protocol (15). Auramine staining
was performed on the decontaminated materials for detec-
tion of acid-fast rods. Standard mycobacterial culturing
was performed at 35°C in liquid MGIT medium and on
solid LJ medium. M. haemophilum–specific culturing was
performed at 30°C on LJ medium with added iron citrate
and in MGIT medium with X-factor-strip added.
Mycobacterial species were identified by using the Inno-
Lipa and more recently using the Inno-Lipa V2 assay
(InnoGenetics, Gent, Belgium) (16). When no growth was
detected after 12 weeks of incubation, the culture results
were listed as negative. Samples were also investigated for
the presence of other bacterial pathogens by conventional
bacterial cultures and by PCR for B. henselae (17). 
Nucleic Acid Isolation 
All clinical materials were processed as described in
Bruijnesteijn et al. (8). DNA was extracted from bacterial
strains and clinical materials according to the method of
Boom et al. (18) with an overnight incubation with pro-
teinase K. 
Primers and Probes 
Genus-specific primers for sequencing the total ITS
region of mycobacteria were described by Frothingham et
al. (19). Primers described previously for a genus-specific
real-time PCR (8) were also used for sequencing a part of
the ITS region directly from clinical materials. Using these
primer sets combined, we applied a seminested PCR
approach to increase the amount of amplicon. The part of
the ITS region used in this real-time PCR shows consider-
able variation between mycobacterial species (20)
(Figure). The primers used in the real-time PCR are genus-
specific, and for the design of the M. haemophilum–spe-
cific minor groove binding (MGB) probe, the intraspecies
and interspecies variation in the amplified ITS region was
investigated. Alignments were made of the sequences of
the M. haemophilum strains and of different mycobacteri-
al species. The Mycobacterium genus–specific probe is
described in Bruijnesteijn et al. (8). 
The  M. haemophilum–specific probe sequence was
checked by using the primer 3 program (http://www-
genome.wi.mit.edu/cgi-bin/primer/primer3_www.cgi/)
(21) and oligo-analyzer 3.0 (http://biotools.idtdna.com/
analyzer/) (IDT Biotools, Coralville, IA), to ensure mini-
mal self-complementary binding and to prevent the pres-
ence of secondary structures. By using the unique features
of the MGB group (22), a short and highly specific probe
could be designed. The probe was designed on the anti-
sense strand to ensure an A/T rich MGB-site. An NCBI
BLAST search was performed to check the specificity of
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Figure. Alignment of internal transcribed spacers (ITS) and partial
23S sequences with primers and probes used for real-time poly-
merase chain (PCR) reaction. (nucleotides [nt] 1 to 301 make up
the total ITS region; nt 302 to 367 are coding for partial 23S gene).
The Mycobacterium haemophilum sequence was derived from 3
different patients, but no variation was found. A, forward primer for
real-time PCR; B, Mycobacterium genus–specific probe; C, M.
haemophilum–specific probe; D, reverse primer for real time–poly-
merase chain reaction.the probe. The primers were prepared by Biolegio
(Biolegio, Malden, the Netherlands), and the MGB probe
was generated by ABI (Applied Biosystems Inc,
Nieuwekerk a/d IJssel, The Netherlands). The broad range
primers P1 and P4 were used for 16S sequencing. Primers
and probes are listed in Table 1, and their positioning in the
genome is illustrated in the Figure. 
Sensitivity Testing 
A plasmid with the ITS sequence of M. haemophilum
was prepared by cloning the PCR product in a vector and
was subsequently quantified (IQ corporation, Groningen,
the Netherlands). Dilution series of this plasmid were test-
ed in duplicate in the genus-specific and the M.
haemophilum–specific real-time PCR. 
Sequence Analysis 
After amplification, PCR products were subjected to a
cycle sequencing reaction with the Big Dye Terminator
Cycle Sequencing ready reaction kit (Applied
Biosystems). Samples underwent electrophoresis and
sequences were detected and analyzed on ABI model 310
DNA sequencer (Applied Biosystems). 
Real-time PCR 
Real-time PCR was performed in 50 µL of reaction
mixture consisting of 25 µL of 2x IQ supermix (Bio-Rad,
Veenendaal, the Netherlands), 20 pmol of each primer,
12.5 pmol of the genus-specific probe or 10 pmol of the M.
haemophilum–specific probe, and 10 µL template. The
PCR thermal profile consisted of an initial incubation of 3
min at 95°C for activation of the enzyme, followed by 50
cycles of 30 s at 95°C, 40 s at 55°C, and 30 s at 72°C.
Amplification, detection, and data analysis were per-
formed with an iCycler IQ real-time detection system
(Bio-Rad). The reaction mix and PCR profile were similar
for both the genus-specific probe and the M. haemophilum
probe.
Each DNA extract was tested by real-time PCR for the
detection of the genus Mycobacterium and species M.
haemophilum. As positive control for the genus-specific
real-time PCR and extraction protocol, a dilution of M.
bovis was used. 
Results
Identification of M. haemophilum in Patient Material 
In 16 (18%) of 89 patients from the CHIMED study, a
mycobacterial infection was suspected, but initially no
species identification could be established. After a positive
signal was generated by the genus-specific real-time PCR
and negative results from the cultures, the amplicons gen-
erated in real-time PCR were sequenced to determine the
species. Sequencing of the ITS fragment formed in the real-
time PCR was difficult, owing to the small amount of
amplicon, but eventually the sequences of 4 patient samples
were successfully derived. On 4 more samples, a seminest-
ed PCR was performed to increase the amount of specific
amplicon. This enhancement of PCR resulted in the suc-
cessful amplification and sequencing of all fragments. No
variation was encountered between the ITS sequences of all
8 strains analyzed here. Because no M. haemophilum ITS
sequences were available in the public databases, 3 com-
plete ITS sequences from M. haemophilum strains isolated
from different CHIMED patients were determined and sub-
mitted to the NCBI database (accession no. AY579398,
AY579399, and AY579400). After specific culturing, the
identity of the strains was confirmed by comparing partial
16S-gene sequences to the sequences in the NCBI
(http://www.ncbi.nlm.nih.gov/) and the RIDOM database
(http://www.ridom.com/). A variable part of the 16S gene
of 330 base pairs was analyzed, and a 100% agreement was
obtained with 16S sequences of 7 available M.
haemophilum strains, including ATCC 29548. The M.
haemophilum strains had at least 4 mismatches in the ana-
lyzed 16S PCR fragment in comparison to other mycobac-
terial species; therefore, all these strains were M.
haemophilum. The identity was also confirmed because of
a minimum of 4 mismatches in the 16S fragment between
the  M. haemophilum sequence and other mycobacterial
species.
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The real-time PCR was designed to the ITS region.
The same conserved primers were used as described
previously. The obtained ITS sequences were used to
select an M. haemophilum–specific probe. 
The detection limit of the M. haemophilum–specific
real-time PCR was assessed at 1 copy per reaction by using
a dilution series of the plasmid standard. The mycobacter-
ial genus–specific PCR was tested simultaneously with the
M. haemophilum–specific PCR and resulted in the same
analytical sensitivity. As determined previously, the sensi-
tivity of the primer set in clinical materials was estimated
to be 1,100 CFU in pus (8). Specificity testing of the M.
haemophilum–specific real-time PCR with 25 other
species and subspecies showed no aspecific reactions. All
50  Bartonella-positive samples from the control group
remained negative in the real-time PCR assay as well. 
Of 16 patients with evidence for M. haemophilum
infection, 9 (56%) were positive on auramine staining, and
9 (56%) were positive in M. haemophilum–specific cul-
tures. In addition, in 1 patient (6%), the pathogen was able
to grow on and in normal mycobacterial cultures. Thirteen
patients (81%) had positive specimens in mycobacterial
genus–specific real-time PCR, 11 of which were also pos-
itive in the M. haemophilum–specific real-time PCR
(Table 2). In contrast, 2 genus-specific M. haemophilum–
negative specimens were positive in the M. haemophilum–
specific real-time PCR. Thus, the 2 PCRs combined yield-
ed 15 positive (94%) patients. These 4 samples with incon-
sistent results all had high threshold cycle values, indicat-
ing that the amount of bacterial DNA present was close to
the detection limit of the assays. This finding was con-
firmed by retesting the samples 5 times in both PCRs,
which yielded 2 or 3 positive reactions in the genus-spe-
cific PCR and in the M. haemophilum-specific PCR. No
correlation was found between the threshold cycle values
in the real-time PCR assay and the culture or auramine-
staining results. All 9 patients with positive specimens by
auramine staining also had positive results in the real-time
PCR assay. Three patients’ conditions were diagnosed by
real-time PCR only. Only 1 patient had a positive culture
while results of the real-time PCR or auramine staining
remained negative. Real-time PCR on the isolate cultured
from this patient resulted in a positive signal. 
The  M. haemophilum–specific culturing method was
less sensitive than the real-time PCR assay. The materials
from the first 6 patients were cultured specifically for M.
haemophilum  after negative results were obtained from
conventional culturing methods. The stored decontaminat-
ed materials were thawed and incubated at 30°C on
enriched media. From these 6 patients, 2 samples (33%)
yielded positive cultures. The materials from the 10 other
patients were cultured directly and yielded positive results
from 7 (70%) patients. M. haemophilum–specific real-time
PCR was performed additionally on all positive cultures to
confirm the specific growth of M. haemophilum. 
From the 16 patients positive for M. haemophilum, 22
samples were collected: 9 tissue biopsy specimens and 13
fine needle aspirates. Of these samples, 19 (86%) were
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samples yielded positive results in auramine staining and
9 (36%) were positive in culture. No discrepancies were
encountered in the real-time PCR assay when all samples
instead of patients were considered. Application of the
real-time PCR assay increased the diagnostic yield by
23%.
Discussion 
M. haemophilum was found to be the causative agent of
lymphadenitis in 16 (18%) of the children included in this
study. Despite the use of specific enriched culture medi-
ums, only 9 (56%) of the 16 M. haemophilum infections
were culture-positive. In contrast, the real-time PCR assay
was positive in 15 (94%) patients.
M. haemophilum infection is not diagnosed frequently
and is therefore not considered a common cause of lym-
phadenitis. However, most studies on children with
mycobacterial lymphadenitis have not used optimized cul-
tures for M. haemophilum, and infection with this species
is therefore likely underdiagnosed. Nevertheless, differ-
ences in geographic distribution may also contribute to the
variable prevalence of M. haemophilum. For instance, no
M. haemophilum was found in children with atypical
mycobacterial lymphadenitis in a study in Ohio (24),
whereas in a study in Israel, M. haemophilum was found in
12 of 29 patients (5). Both studies used appropriate culture
conditions for M. haemophilum. Another reason for an
underestimation of the occurrence of M. haemophilum
infections is the misleading positive skin test. M.
haemophilum can induce similar reactions in the Mantoux
test as M. tuberculosis and could be misdiagnosed when no
positive cultures are obtained (4,5). 
The natural source of M. haemophilum infection is
unknown. Its geographic distribution appears to be related
to the occurrence of large bodies of water (6). A few natu-
ral reservoirs have been suggested (25–27), but studies
focusing on the environmental reservoirs of NTM tend to
culture without optimized conditions for M. haemophilum,
which may be the reason the organism is rarely found. The
temperature for culture is often too high (28,29), cultures
do not contain hemin or iron citrate, or the incubation time
is too short (30). Only 1 study detected M. haemophilum in
water distribution systems, although the culture method
was not optimal (26). Therefore, M. haemophilum may be
widely distributed and present in several natural reser-
voirs; water is the most likely one (12). 
M. haemophilum is slow growing, iron dependent, and
has an optimal growth temperature from 30°C to 32°C. It is
unable to grow on routine media such as LJ Middlebrook
7H9 and 7H10, or BACTEC broth. Media used to recover
M. haemophilum on primary isolation include commercial-
ly available solid media or broth enriched with ferric
ammonium citrate or hemin (31). Chocolate agar and lysed
blood agar are mentioned as inexpensive and suitable alter-
natives (32,33). Little is known about the sensitivities of
direct culturing of clinical materials for the recovery of M.
haemophilum, and not all media have equal capacity for
stimulating the growth (34). 
Because application of culture conditions specific for
M. haemophilum are not likely to become standard in clin-
ical microbiologic laboratories, including this specific
diagnosis might be useful for molecular methods. A
species-specific real-time PCR was developed to identify
M. haemophilum directly in patient materials. Because M.
haemophilum was not expected to be an important
pathogen, no specific culturing was applied initially. After
the recognition of M. haemophilum by molecular methods,
the culture methods were optimized, which resulted in
70% positive cultures. Additionally, all stored decontami-
nated materials from culture-negative specimens were
recultured under M. haemophilum–specific conditions.
Most likely because of these additional freezing and thaw-
ing steps, cultures were less sensitive for these materials
and resulted in 33% positive cultures. 
Identification of M. haemophilum in patient materials
was performed by 16S sequencing (of cultures) and ITS
sequencing. Two versions of a commercial reverse line
hybridization assay (the Inno-Lipa assay and the V2 Inno-
Lipa assay) were also used for the recognition of M.
haemophilum, but these tests can only be applied on cul-
tured isolates. The V2 Inno-Lipa can identify M.
haemophilum by a specific probe, which was absent in the
previous version of the Inno-Lipa assay. The reactions
were uniformly positive only for M. haemophilum in the
V2 Inno-Lipa. 
The design of the real-time PCR MGB probe was based
on the ITS sequences that were obtained from the patient
materials and reference strains. An MGB probe enables
specific detection of the target by using a shorter sequence
than that of a TaqMan probe or a molecular beacon. 
Sequencing of the ITS amplicons from the genus-spe-
cific real-time PCR on patient samples was difficult
because of the small amounts of target sequence. To
enhance the specific amplification, a seminested PCR was
applied. Of the 8 clinical samples from which sequences
were obtained, 4 samples also yielded positive cultures
once the culture protocol was optimized. The ITS and 16S
sequences derived from the cultured isolates confirmed the
authenticity of the identified pathogen. 
In this study, both fine needle aspiration and excisional
biopsy were not applied as treatment options but as diag-
nostic procedures. Complete surgical excision of the
affected lymph nodes is considered as the treatment of
choice for atypical mycobacterial lymphadenitis (1,35,36).
However, surgical excision leaves scarring and carries the
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(37,38). Antimicrobial therapy as a conservative treatment
is currently the topic of our study. Incision and drainage
increase the risk for sinus tract formation or recurrence of
infection (33,35). This risk also applies to fine needle aspi-
ration, but the usage of fine needle aspirate for PCR will
provide a rapid diagnosis and thereby allow treatment to
begin earlier and thus lower the risk for complications. 
In conclusion, for detecting and identifying M.
haemophilum, real-time PCR is a sensitive and specific
assay suitable for direct application on clinical materials.
In this study, by using the real-time PCR, M. haemophilum
was shown to be an important pathogen involved in lym-
phadenitis. Because of special growth requirements, the
clinical spectrum of diseases associated with M.
haemophilum is largely unknown. Real-time PCR may be
particularly useful for testing clinical samples such as spu-
tum, cerebrospinal fluid, and synovial fluid for M.
haemophilum to determine the role of M. haemophilum in
more detail. 
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